No De-Risk? No Reward! 2025 R&D Innovation Workshop Replay

By 

Event Innovation Management

Watch the Replay

View the abridged version of our “No De-Risk? No Reward!” workshop from CParity’s 2025 R&D Innovation Forum.

Download slide deck

The R&D Incubation Gap: High Stakes, Low Efficiency

While nearly 75% of innovation leaders view the incubation phase—converting early discoveries into high-potential, low-risk commercial opportunities—as critical to corporate growth, only 15% consider their organizations effective at it, and 0% rate themselves efficient. R&D teams frequently find themselves trapped between competing demands: driving strategic upside, eliminating downside risks, and justifying investments to stakeholders before substantial capital is deployed. Without structured incubation processes, early initiatives often stall or drift into “zombie projects” that drain budget and technical bandwidth without advancing toward commercial viability.

 The Trap of Subjective Prioritization and False Consensus

When organizations attempt to evaluate these uncertainties intuitively, subjective decision-making routinely distorts project priorities. Across interactive workshop exercises analyzing early-stage initiatives, participants consistently defaulted to consensus voting, loud-voice dominance, or narrow feasibility-first filters to rank project hurdles. While teams quickly reached internal alignment, none of the participants felt fully confident that their prioritization was objectively correct, illustrating how subjective consensus is often mistaken for actual risk reduction.

Why Traditional Financial Models Penalize Breakthrough Innovation

Traditional financial metrics worsen this breakdown by penalizing the adoption timelines inherent to breakthrough innovation. In a case study of Rogers Corporation’s frequency-hopping antenna project with the U.S. Army Rangers, conventional discounted cash flow modeling heavily discounted multi-year vehicle specification and sales lags. This produced a misleading -$102 million Net Present Value (NPV) that branded the company’s highest-priority strategic program as the “worst” project in its portfolio. Successfully de-risking high-uncertainty R&D requires shifting away from static hurdle rates toward systematic decision frameworks that drive upside, eliminate fatal flaws early, and build defensible business cases.